A 42-year-old woman with a 2-year history of myasthenia gravis is brought to the emergency department with acute respiratory distress, dysphagia, and severe generalized weakness. She had been on pyridostigmine 60 mg four times daily but missed her doses for 2 days due to a gastrointestinal illness. On examination, she has marked ptosis, facial weakness, and weak respiratory effort. Arterial blood gas shows pH 7.28, PaCO₂ 62 mmHg, PaO₂ 68 mmHg. Which of the following best describes the underlying synaptic dysfunction in her acute deterioration?

Explanation

## Myasthenic Crisis: Pathophysiology and Acute Decompensation **Key Point:** Myasthenic crisis occurs when the number of functional acetylcholine receptors (AChRs) falls below the critical threshold needed to generate sufficient end-plate potentials for muscle contraction, particularly in muscles required for respiration. ### Mechanism of Crisis in This Patient **High-Yield:** The patient's crisis is precipitated by **loss of anticholinesterase coverage** (missed pyridostigmine doses). Without acetylcholinesterase inhibition, acetylcholine is rapidly degraded in the synaptic cleft, leaving insufficient neurotransmitter to activate the already-reduced pool of AChRs. ### The Critical Threshold Concept ```mermaid flowchart TD A[Anti-AChR antibodies destroy receptors]:::outcome --> B[AChR density decreases] B --> C{AChR density vs<br/>Critical Threshold?}:::decision C -->|Above threshold| D[Adequate NMJ transmission<br/>Patient compensated]:::outcome C -->|Below threshold| E[Inadequate transmission<br/>Muscle weakness]:::outcome F[Anticholinesterase inhibitor]:::action --> G[Prolongs ACh in cleft] G --> H[Increases probability of<br/>ACh-AChR binding] H --> I[Compensates for low AChR density]:::action J[Missed anticholinesterase doses]:::urgent --> K[Loss of compensatory mechanism] K --> L[Acute decompensation<br/>Myasthenic Crisis]:::urgent ``` ### Why This Patient Decompensated | Factor | Contribution | |--------|---------------| | Baseline AChR loss | ~70–80% reduction from anti-AChR antibodies | | Anticholinesterase effect | Normally compensates by prolonging ACh half-life 5–10 fold | | Missed doses (2 days) | Loss of compensatory mechanism; ACh degraded rapidly | | Respiratory muscles | Most sensitive to NMJ dysfunction; require highest safety margin | | **Result** | Insufficient ACh-AChR interactions → respiratory failure | **Clinical Pearl:** Myasthenic crisis typically involves respiratory muscle weakness (diaphragm, intercostals) and bulbar weakness (dysphagia, dysarthria), requiring ICU admission and mechanical ventilation. ### Differential: Cholinergic Crisis **Warning:** Do NOT confuse myasthenic crisis with **cholinergic crisis** (excessive anticholinesterase leading to depolarization blockade). Cholinergic crisis presents with **muscarinic symptoms** (bronchospasm, bradycardia, miosis, salivation) and occurs with overdose, not missed doses. ### Management Principles 1. **Immediate:** Secure airway; mechanical ventilation if needed 2. **Immunotherapy:** IV immunoglobulin (IVIg) or plasmapheresis to remove circulating anti-AChR antibodies 3. **Avoid:** Anticholinesterase drugs initially (risk of cholinergic crisis if misdiagnosed as cholinergic) 4. **Long-term:** Resume immunosuppression (corticosteroids, azathioprine, mycophenolate) **Mnemonic:** **CRISIS** in MG = **C**ritical threshold breached, **R**educed AChR, **I**nadequate anticholinesterase, **S**evere weakness, **I**ntensive care needed, **S**upport ventilation. [cite:Harrison 21e Ch 380; Guyton & Hall Ch 9]